Top Page
China Molybdenum Co
(OTC:3993)
China Molybdenum Co (3993) vs. iShares MSCI Hong Kong ETF (EWH)
China Molybdenum Co Business Overview & Revenue Model
China Molybdenum Co Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 213.03B | 186.27B | 172.99B | 173.86B | 112.98B |
| Gross Profit | 35.25B | 17.83B | 16.06B | 16.32B | 8.45B |
| EBITDA | 31.39B | 20.17B | 17.10B | 10.56B | 9.01B |
| Net Income | 13.53B | 8.25B | 6.07B | 5.11B | 2.33B |
Balance Sheet | |||||
| Total Assets | 170.24B | 172.97B | 165.02B | 137.45B | 122.44B |
| Cash, Cash Equivalents and Short-Term Investments | 36.94B | 39.00B | 36.88B | 31.44B | 24.38B |
| Total Debt | 29.64B | 50.86B | 48.35B | 46.86B | 45.03B |
| Total Liabilities | 84.29B | 101.01B | 102.98B | 89.19B | 75.11B |
| Stockholders Equity | 71.02B | 59.54B | 51.70B | 39.85B | 38.89B |
Cash Flow | |||||
| Free Cash Flow | 27.49B | 2.62B | 4.94B | 1.91B | 870.66M |
| Operating Cash Flow | 32.39B | 15.54B | 15.45B | 6.19B | 8.49B |
| Investing Cash Flow | -1.16B | -10.66B | ― | ― | ― |
| Financing Cash Flow | -30.57B | -8.61B | ― | 7.89B | 422.30M |
China Molybdenum Co Technical Analysis
China Molybdenum Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $198.18B | 10.71 | 22.95% | 3.34% | 12.14% | 53.33% | |
44 Neutral | C$976.20M | -6.71 | -13.35% | 2.69% | 17.20% | -32.62% | |
| $380.38M | 8.16 | 7.21% | 0.56% | ― | ― | ||
| €128.77M | ― | -26.13% | ― | ― | ― | ||
79 Outperform | HK$17.18B | 8.68 | 17.83% | 3.54% | 36.51% | 66.77% | |
76 Outperform | HK$33.98B | 44.04 | 25.55% | 1.53% | 40.22% | 46.48% | |
62 Neutral | HK$57.23B | ― | -8.74% | 5.07% | -59.41% | -169.49% |
China Molybdenum Co Corporate Events
CMOC Group Limited held its 2024 annual general meeting and the 2025 first class meetings for A and H shareholders on May 30, 2025. Key outcomes included the approval of the payment of a final dividend, the appointment of new executive directors, the resignation of a non-executive director and chairman of the board, and a change in the authorized representative. These developments are expected to impact the company’s governance structure and potentially influence its strategic direction.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co has announced significant leadership and structural changes, including the appointment of Liu Jianfeng as the new chairman of the board. The company has also made adjustments to the composition of its board committees, which may impact its strategic direction and governance. These changes are part of a broader effort to optimize the company’s management and investment strategies, potentially influencing its market position and stakeholder relations.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co, operating under CMOC Group Limited, announced a final ordinary cash dividend of RMB 2.55 per 10 shares for the financial year ending December 31, 2024. The dividend, approved on May 30, 2025, will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.08991, with a payment date set for July 18, 2025. The announcement includes details on withholding tax rates applicable to different shareholder categories, impacting non-resident enterprises and individual investors in mainland China.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has announced the composition of its board of directors and their roles within the company. The board includes executive, non-executive, and independent non-executive directors, with specific members serving on various committees such as the Audit and Risk Committee, Nomination and Governance Committee, Remuneration Committee, and Strategic and Sustainability Committee. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic direction and stakeholder confidence.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co., Ltd. announced the successful completion of payment for its 2020 first tranche medium-term notes, which were issued on May 28, 2020, with a total amount of RMB1 billion, a coupon rate of 4.20%, and a term of five years. This completion marks a significant financial milestone for the company, reinforcing its financial stability and commitment to fulfilling its financial obligations, which could positively impact its reputation and stakeholder confidence.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co, operating under the name CMOC Group Limited, has announced a final cash dividend for the year ending December 31, 2024. The dividend is set at RMB 2.55 per 10 shares, with shareholder approval scheduled for May 30, 2025. The announcement includes updated information on the withholding tax rates applicable to different types of shareholders, with non-resident enterprises facing a 10% tax rate and resident individuals a 20% rate. The specifics of the dividend payment, including the default currency and payment date, are yet to be announced.
CMOC Group Limited announced the resignation of its non-executive director and chairman, Mr. Yuan Honglin, and executive director and vice chairman, Mr. Li Chaochun, due to personal reasons. Their departures will not affect the company’s operations or board functionality. The company has proposed the appointment of Mr. Que Chaoyang and Mr. Liu Jianfeng as new executive directors, subject to shareholder approval. These appointments bring extensive experience in mining, investment, and corporate governance, potentially strengthening CMOC’s strategic and operational capabilities.
China Molybdenum Co has announced the composition of its board of directors and the roles they will serve within the company’s committees. This update provides clarity on the leadership structure, which could impact the company’s strategic direction and governance, potentially affecting its market positioning and stakeholder interests.
CMOC Group Limited, a joint stock company incorporated in China, has announced its annual general meeting for 2024, scheduled to be held on May 30, 2025, in Luoyang City, Henan Province. The meeting will address several resolutions, including the approval of financial reports, profit distribution plans, and the appointment of external auditors for 2025. Additionally, the company will consider proposals for purchasing structured deposits and wealth management products, as well as authorizations for issuing debt financing instruments and additional shares. These resolutions are aimed at strengthening the company’s financial management and operational strategies.
China Molybdenum Co, a joint stock company incorporated in the People’s Republic of China, has announced a meeting for H Shareholders scheduled for May 30, 2025. The meeting aims to consider and approve special resolutions regarding the cancellation of repurchased shares and the reduction of registered capital, as well as changes to the registered capital and amendments to the company’s Articles of Association. This announcement indicates a strategic move to adjust the company’s capital structure, which could impact its financial positioning and shareholder value.
CMOC Group Limited has announced its unaudited financial results for the first quarter of 2025, reporting a slight decrease in operating revenue by 0.25% compared to the same period last year. However, the company saw a significant increase in net profit attributable to shareholders, which rose by 90.47%, indicating strong profitability despite a substantial drop in net cash flow from operating activities by 76.02%. The company’s total assets and net assets attributable to shareholders also increased, reflecting a stable financial position and potential positive outlook for stakeholders.
CMOC Group Limited has announced that a board meeting will be held on April 25, 2025, to consider and approve the publication of its quarterly results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
CMOC Group Limited announced a significant increase in the production of its main products, copper, cobalt, and niobium, during the first quarter of 2025, with respective year-on-year increases of 15.65%, 20.68%, and 4.39%. This growth, coupled with higher sales prices, resulted in better-than-expected operating indicators, positioning the company for strategic expansion and high-quality development throughout the year.